JENAVALVE TECHNOLOGY
HQ - Irvine, CA
Summary
JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR).
Deals Overview
Total Deals2
Valued Deals1
Total Value£85M
Avg. Deal Size£85M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.